Oric Pharmaceuticals, Inc.
ORIC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001796280
In the last 90 days, Oric Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 5 sales; 180 institutions reported holding it in 13F filings for Q2 2026, worth $1.34B in total; Viking Global Investors is the only superinvestor holding it.
Q3 2021 vs. Q2 2021
How the institutions holding Oric Pharmaceuticals, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 78 | 82 | +4 |
| Shares | 36.1M | 36.4M | +276.1K (+0.8%) |
| Value | $639.4M | $762.1M | +$122.7M (+19.2%) |
New holders (10)
Institutions that held Oric Pharmaceuticals, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Suvretta Capital Management, LLC | 149,100 | $3.12M | 0.05% |
| SG Americas Securities, LLC | 25,235 | $528.0K | 0.00% |
| Susquehanna Fundamental Investments, LLC | 21,399 | $447.0K | 0.01% |
| M&T Bank Corp | 14,635 | $306.0K | 0.00% |
| Quantbot Technologies LP | 2,700 | $56.0K | 0.00% |
| US Bancorp | 1,355 | $28.0K | 0.00% |
| Russell Investments Group, Ltd. | 1,004 | $20.0K | 0.00% |
| Signaturefd, LLC | 80 | $2.00K | 0.00% |
| Berman Capital Advisors, LLC | 113 | $2.00K | 0.00% |
| Parallel Advisors, LLC | 2 | $0 | 0.00% |
Sold out (6)
Institutions that held Oric Pharmaceuticals, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Ra Capital Management, L.P. | 584,000 | $10.3M |
| Millennium Management LLC | 231,853 | $4.10M |
| Two Sigma Investments, LP | 30,641 | $542.0K |
| Qube Research & Technologies Ltd | 22,512 | $398.0K |
| Point72 Hong Kong Ltd | 1,895 | $34.0K |
| O'Shaughnessy Asset Management, LLC | 1,544 | $27.0K |